TNF and Crohn disease: However, due to the multitude of human studies demonstrating that patients receiving TNF-α inhibitors for chronic inflammatory diseases (rheumatoid arthritis, Crohn disease) can develop reactivation TB disease [7], [8], [18], we acknowledge the significant risks of such treatment.